Market Overview:
The global respiratory infectious disease diagnostics market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of respiratory infectious diseases, technological advancements in diagnostic tests, and rising demand for point-of-care testing. The global respiratory infectious disease diagnostics market is segmented by type, application, and region. By type, the market is divided into mechanical tests, imaging tests, and in vitro diagnostics (IVD) tests. By application, the market is classified into hospitals, clinical laboratories, and others. Geographically speaking North America dominates the global respiratory infectious disease diagnostics with a share of 36%, followed by Europe with 31%. Asia Pacific holds third place with a share of 23%.
Product Definition:
Respiratory Infectious Disease Diagnostics is the process of identifying and diagnosing respiratory infections, such as pneumonia, bronchitis, and the common cold. Respiratory infections can be serious and even deadly if left untreated. Early diagnosis and treatment is essential for preventing serious illness or death. Respiratory Infectious Disease Diagnostics helps healthcare providers to quickly identify and treat respiratory infections, which can save lives.
Mechanical Tests:
The global mechanical tests market is expected to grow at a lucrative rate during the forecast period. The key drivers attributing to its rapid growth include rising prevalence of chronic respiratory diseases and increasing demand for point of care diagnostic devices. Moreover, growing R&D activities pertaining to development of novel techniques in molecular diagnostics are also anticipated to boost the mechanical tests market growth over the forecast period.
Imaging Tests:
Imaging tests are diagnostic procedures that involve the use of X-rays, computed tomography (CT), ultrasound or magnetic resonance imaging (MRI). These tests help in obtaining detailed images of internal organs and tissues. Imaging tests are used for the diagnosis of respiratory diseases such as pneumonia, bronchitis & other chronic obstructive pulmonary diseases (COPD) and infectious diseases such as tuberculosis & lung cancer.
Application Insights:
Based on application, the global respiratory infectious disease diagnostics market is segmented into hospitals, clinical laboratories and others. Hospitals held the largest share in 2017 owing to factors such as increasing prevalence of diseases and growing investments by governments for the development of healthcare infrastructure.
Respiratory infections are a major concern in hospitals as they can spread rapidly within a hospital environment due to close contact between people. The majority of these infections are caused by bacteria or viruses that are endemic to specific regions or countries but have been reported worldwide due to international travel & trade activities. Thus, an increase in incidence of Respiratory Infectious Diseases (RID) has resulted in increased demand for diagnostic tests globally which is expected to drive growth over forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key respiratory infectious disease diagnostic players, such as Quidel Corporation; Abbott Laboratories; and Bio-Rad Laboratories, Inc., in this region. The U.S.-based companies are engaged in developing novel technologies for the diagnosis of various infectious diseases using different platforms such as blood gas analysis and culture techniques that provide rapid results with high accuracy rates.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to increasing incidence rates of respiratory infections coupled with rising healthcare expenditure levels in emerging countries like India and China. In addition, favorable government initiatives pertaining to R&D investments for improving patient care standards are anticipated to fuel regional growth over the next eight years time frame till 2030 ending year’s trends emerge due to which demand & supply factors will have their own impact on overall market dynamics during this period).
Growth Factors:
- Increasing incidence of respiratory infections: The global incidence of respiratory infections is increasing due to the changing lifestyle and environmental conditions. This is driving the demand for respiratory infectious disease diagnostics products and services.
- Growing awareness about respiratory infectious diseases: There is growing awareness among people about the symptoms, causes, and treatment options for various respiratory infectious diseases. This is fueling the demand for diagnostic tests for these diseases.
- Technological advancements in diagnostic tests: There has been a significant advancement in diagnostic technologies over the past few years that has led to improved accuracy and speed of diagnosis of respiratory infectious diseases. This is boosting the growth of the market for Respiratory Infectious Disease Diagnostics products and services worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Respiratory Infectious Disease Diagnostics Market Research Report
By Type
Mechanical Tests, Imaging Tests, In Vitro Diagnostics (IVD) Tests
By Application
Hospitals, Clinical Laboratories, Others
By Companies
Abbott Laboratories, Thermo Fisher Scientific., Koninklijke Philips, Cardinal Health, COSMED, Smiths Group, NIHON KOHDEN CORPORATION, Becton, Dickinson, F.Hoffmann
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
159
Number of Tables & Figures
112
Customization Available
Yes, the report can be customized as per your need.
Global Respiratory Infectious Disease Diagnostics Market Report Segments:
The global Respiratory Infectious Disease Diagnostics market is segmented on the basis of:
Types
Mechanical Tests, Imaging Tests, In Vitro Diagnostics (IVD) Tests
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinical Laboratories, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Thermo Fisher Scientific.
- Koninklijke Philips
- Cardinal Health
- COSMED
- Smiths Group
- NIHON KOHDEN CORPORATION
- Becton
- Dickinson
- F.Hoffmann
Highlights of The Respiratory Infectious Disease Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Mechanical Tests
- Imaging Tests
- In Vitro Diagnostics (IVD) Tests
- By Application:
- Hospitals
- Clinical Laboratories
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Respiratory Infectious Disease Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Respiratory Infectious Disease Diagnostics is a company that provides diagnostic tests for respiratory infections. These tests can help doctors determine the cause of a respiratory infection and recommend the best course of treatment.
Some of the major companies in the respiratory infectious disease diagnostics market are Abbott Laboratories, Thermo Fisher Scientific., Koninklijke Philips, Cardinal Health, COSMED, Smiths Group, NIHON KOHDEN CORPORATION, Becton, Dickinson, F.Hoffmann.
The respiratory infectious disease diagnostics market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Respiratory Infectious Disease Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Respiratory Infectious Disease Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Respiratory Infectious Disease Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Respiratory Infectious Disease Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Respiratory Infectious Disease Diagnostics Market Size & Forecast, 2018-2028
4.5.1 Respiratory Infectious Disease Diagnostics Market Size and Y-o-Y Growth
4.5.2 Respiratory Infectious Disease Diagnostics Market Absolute $ Opportunity
Chapter 5 Global Respiratory Infectious Disease Diagnostics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Respiratory Infectious Disease Diagnostics Market Size Forecast by Type
5.2.1 Mechanical Tests
5.2.2 Imaging Tests
5.2.3 In Vitro Diagnostics (IVD) Tests
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Respiratory Infectious Disease Diagnostics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Respiratory Infectious Disease Diagnostics Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinical Laboratories
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Respiratory Infectious Disease Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Respiratory Infectious Disease Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Respiratory Infectious Disease Diagnostics Analysis and Forecast
9.1 Introduction
9.2 North America Respiratory Infectious Disease Diagnostics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Respiratory Infectious Disease Diagnostics Market Size Forecast by Type
9.6.1 Mechanical Tests
9.6.2 Imaging Tests
9.6.3 In Vitro Diagnostics (IVD) Tests
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Respiratory Infectious Disease Diagnostics Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinical Laboratories
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Respiratory Infectious Disease Diagnostics Analysis and Forecast
10.1 Introduction
10.2 Europe Respiratory Infectious Disease Diagnostics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Respiratory Infectious Disease Diagnostics Market Size Forecast by Type
10.6.1 Mechanical Tests
10.6.2 Imaging Tests
10.6.3 In Vitro Diagnostics (IVD) Tests
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Respiratory Infectious Disease Diagnostics Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinical Laboratories
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Respiratory Infectious Disease Diagnostics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Respiratory Infectious Disease Diagnostics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Respiratory Infectious Disease Diagnostics Market Size Forecast by Type
11.6.1 Mechanical Tests
11.6.2 Imaging Tests
11.6.3 In Vitro Diagnostics (IVD) Tests
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Respiratory Infectious Disease Diagnostics Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinical Laboratories
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Respiratory Infectious Disease Diagnostics Analysis and Forecast
12.1 Introduction
12.2 Latin America Respiratory Infectious Disease Diagnostics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Respiratory Infectious Disease Diagnostics Market Size Forecast by Type
12.6.1 Mechanical Tests
12.6.2 Imaging Tests
12.6.3 In Vitro Diagnostics (IVD) Tests
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Respiratory Infectious Disease Diagnostics Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinical Laboratories
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Respiratory Infectious Disease Diagnostics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Respiratory Infectious Disease Diagnostics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Respiratory Infectious Disease Diagnostics Market Size Forecast by Type
13.6.1 Mechanical Tests
13.6.2 Imaging Tests
13.6.3 In Vitro Diagnostics (IVD) Tests
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Respiratory Infectious Disease Diagnostics Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinical Laboratories
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Respiratory Infectious Disease Diagnostics Market: Competitive Dashboard
14.2 Global Respiratory Infectious Disease Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Thermo Fisher Scientific.
14.3.3 Koninklijke Philips
14.3.4 Cardinal Health
14.3.5 COSMED
14.3.6 Smiths Group
14.3.7 NIHON KOHDEN CORPORATION
14.3.8 Becton
14.3.9 Dickinson
14.3.10 F.Hoffmann
